Yubo International Biotech Ltd (YBGJ)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-5K 0 5K 10K 15K Q3 '24: 0 Q4 '24: -18 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 12.4K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-3K 0 3K 6K 9K Q3 '24: 0 Q4 '24: -13 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 8.2K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '24: -532.8K Q4 '24: -357.3K Q1 '25: -467.3K Q2 '25: -249.7K Q3 '25: -310.1K Q4 '25: -285.5K Q1 '26: -289.3K Q2 '26: -238.9K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '24: -621.1K Q4 '24: -146.7K Q1 '25: -435.6K Q2 '25: -230.3K Q3 '25: -310.2K Q4 '25: -177K Q1 '26: -272.6K Q2 '26: -247.9K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

-1.5K 0 1.5K 3K 4.5K Q3 '24: 0 Q4 '24: -5 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 4.2K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '24: 353.3K Q4 '24: -932.7K Q1 '25: -392K Q2 '25: -14K Q3 '25: -308K Q4 '25: -128.8K Q1 '26: -207.2K Q2 '26: -84.1K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '22: 55.2K Q4 '22: -689.5K Q1 '23: -32.7K Q2 '23: -153K Q3 '23: 5.1K Q1 '24: -349.5K Q1 '25: -398.2K Q1 '26: -207.2K Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q1 '24 Q1 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '24: 12M Q2 '24: 119.8M Q3 '24: 119.8M Q1 '25: 119.8M Q2 '25: 119.8M Q3 '25: 147.9M Q1 '26: 170.4M Q2 '26: 170.4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.11 -0.07 -0.04 0.00 0.04 0.07 0.11 Q3 '24: -0.10 Q4 '24: -0.02 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.01 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.